Jianxiu Cui

Beijing, 100020, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.

Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.

Journal: Mediators of inflammation

Published: October 29, 2025

Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.

Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.

Journal: Mediators of inflammation

Published: October 29, 2025

Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.

Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.

Journal: Mediators of inflammation

Published: October 29, 2025

Deep learning for real-time detection of breast cancer presenting pathological nipple discharge by ductoscopy.

Deep learning for real-time detection of breast cancer presenting pathological nipple discharge by ductoscopy.

Journal: Frontiers in oncology

Published: November 20, 2022

Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.

Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.

Journal: Medicine

Published: October 03, 2019

Demethylation of the Cosmc Promoter Alleviates the Progression of Breast Cancer Through Downregulation of the Tn and Sialyl-Tn Antigens.

Demethylation of the Cosmc Promoter Alleviates the Progression of Breast Cancer Through Downregulation of the Tn and Sialyl-Tn Antigens.

Journal: Cancer management and research

Published: May 05, 2019

The prognostic value and potential drug target of phosphatase and tensin homolog in breast cancer patients: A meta-analysis.

The prognostic value and potential drug target of phosphatase and tensin homolog in breast cancer patients: A meta-analysis.

Journal: Medicine

Published: September 09, 2017

Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis.

Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis.

Journal: Oncotarget

Published: July 04, 2016

Showing 1-8 of 8

Last Updated: 09/26/2026